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Development of the pancreas and cerebellum require Pancreas-speciﬁc transcription factor-1a (Ptf1a),
which encodes a subunit of the transcription factor complex PTF1. Ptf1a is required in succession for
speciﬁcation of the pancreas, proper allocation of pancreatic progenitors to endocrine and exocrine fates,
and the production of digestive enzymes from the exocrine acini. In several neuronal structures,
including the cerebellum, hindbrain, retina and spinal cord, Ptf1a is transiently expressed and promotes
inhibitory neuron fates at the expense of excitatory fates. Transcription of Ptf1a in mouse is maintained in
part by PTF1 acting on an upstream autoregulatory enhancer. However, the transcription factors and
enhancers that initially activate Ptf1a expression in the pancreas and in certain structures of the nervous
system have not yet been identiﬁed. Here we describe a zebraﬁsh autoregulatory element, conserved
among teleosts, with activity similar to that described in mouse. In addition, we performed a
comprehensive survey of all non-coding sequences in a 67 kb interval encompassing zebraﬁsh ptf1a,
and identiﬁed several neuronal enhancers, and an enhancer active in the ventral pancreas prior to
activation of the autoregulatory enhancer. To test the requirement for autoregulatory control during
pancreatic development, we restored ptf1a function through BAC transgenesis in ptf1a morphants, either
with an intact BAC or one lacking the autoregulatory enhancer. We ﬁnd that ptf1a autoregulation is
required for development of the exocrine pancreas and full rescue of the ptf1a morphant phenotype.
Similarly, we demonstrate that a ptf1a locus lacking the early enhancer region is also capable of rescue,
but only supports formation of a hypoplastic exocrine pancreas. Through our dissection of the complex
regulatory control of ptf1a, we identiﬁed separate cis-regulatory elements that underlie different aspects
of its expression and function, and further demonstrated the requirement of maintained ptf1a expression
for normal pancreatic morphogenesis. We also identiﬁed a novel enhancer that mediates initiation of
ptf1a expression in the pancreas, through which the signals that specify the ventral pancreas are
expected to exert their action.
& 2013 Elsevier Inc. All rights reserved.Introduction
The vertebrate pancreas forms from evaginations of the
endoderm, the dorsal and ventral pancreatic buds, that later
fuse to produce a single organ composed of hormone-secreting
endocrine cells, digestive enzyme-secreting exocrine cells, and
duct cells. In the zebraﬁsh, the dorsal bud forms by 24 h post
fertilization (hpf) (Biemar et al., 2001) and exclusively pro-
duces endocrine cells of the principal islet. The ventral budll rights reserved.
Medicine and Therapeutics,
f Pennsylvania, Philadelphiaarises at 34 hpf and grows toward the dorsal bud-derived islet,
with which it completely merges by 52 hpf (Field et al., 2003).
The pancreas speciﬁc transcription factor 1a (Ptf1a) has a
critical role in pancreatic development. Loss of Ptf1a in mice
results in loss of the ventral pancreatic bud and early arrest in
development of the dorsal bud (Krapp et al., 1998; Kawaguchi
et al., 2002). In zebraﬁsh, depletion of ptf1a through antisense
morpholinos results in the absence of a ventral bud, but the
dorsal bud is unaffected (Lin et al., 2004; Zecchin et al., 2004).
Despite the critical requirement for Ptf1a in early pancreatic
development, the signals that initiate its expression in the
ventral pancreas are poorly characterized. vHNF1 is an attrac-
tive candidate for the direct activation of Ptf1a, since loss of
vHNF1 in mouse results in loss of endodermal Ptf1a expression
(Haumaitre et al., 2005) and similarly in zebraﬁsh results in the
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Identiﬁcation of the Ptf1a regulatory elements that mediate the
activation of its pancreatic expression is therefore an impor-
tant step to determine the involvement of speciﬁc transcrip-
tion factors in ventral pancreas speciﬁcation.
In addition to its function in pancreas speciﬁcation, Ptf1a has a
dosage sensitive role in the allocation of pancreatic progenitors to
the exocrine and endocrine compartments in both mouse (Fukuda
et al., 2008; Schaffer et al., 2010) and zebraﬁsh (Dong et al., 2008).
A cross-repressive loop between the pro-exocrine Ptf1a and the
pro-endocrine Nkx6 operates to segregate endocrine and exocrine
cells in the pancreas (Schaffer et al., 2010). Both Ptf1a and Nkx6.1
are known to activate their own expression (Masui et al., 2008;
Iype et al., 2004) and the autoregulatory function of both genes in
the context of competing cell fate determinants has been proposed
to either confer stability to the bipotential progenitor state (Huang
et al., 2007) or to maintain stability of the commitment to a given
lineage after the resolution of the bipotential fate choice.
Ptf1a is also important in the development of several popula-
tions of inhibitory neurons. Speciﬁcally, in the cerebellar primor-
dium Ptf1a is expressed in the ventricular zone, a germinative zone
that generates progenitors of the inhibitory Purkinje cells and
interneurons (Pascual et al., 2007). Loss of Ptf1a leads to a loss of
Purkinje cells and interneurons during embryonic development,
which secondarily results in postnatal cerebellar agenesis in mice
(Hoshino et al., 2005) and humans (Sellick et al., 2004). Within
more caudal rhombomeres of the mouse hindbrain, Ptf1a expres-
sing domains contribute inhibitory neurons to the cochlear
nucleus (Yamada et al., 2007) and climbing ﬁber neurons of the
precerebellar system (Fujiyama et al., 2009). Similarly, in zebraﬁsh
the ptf1a expressing domain contributes to the precerebellar
system (Bae et al., 2009). Within the dorsal spinal cord, Ptf1a is
required for the generation of two populations of inhibitory
interneurons (Glasgow et al., 2005). Also, in the retina Ptf1a isTable 1
Primers used to subclone candidate enhancer sequences and for BAC recombineering.
+1ptf1a F GCAATGTTGCTATTAGTATCCCGTA
+1ptf1a R TGCTTAAGCTCAACCAGCCTA
attB1-17ptf1a F GGGGACAAGTTTGTACAAAAAAGCAGGCCAC
attB2-17ptf1a R GGGGACCACTTTGTACAAGAAAGCTGGGTAT
attB1+36ptf1a F GGGGACCACTTTGTACAAGAAAGCTGGGTTG
attB2+36ptf1a R GGGACAAGTTTGTACAAAAAAGCAGGCTTTG
attB1-3ptf1a F GGGGACAAGTTTGTACAAAAAAGCAGGCCAA
attB2-3ptf1a R GGGGACCACTTTGTACAAGAAAGCTGGGTGT
Autoreg2kb F ACTAATCTGAAACAGCCTGCG
Autoreg1.3 kb F TTTTAACGCGTCGGACATTG
Autoreg R TCAATTGCCATTTTAAACGCT
Synth-S ACCGGTCGCATGTGGCTGGATTCCCAGCACC
Synth-AS GCCGGCGTGGGAATCACACCACTTGCGCCGG
35hom-FRT3-tet R AGCGTGTGAACTCCCACAACGCATCATGAGG
35hom-tet F ACAGGTTTACAACCAATGTGCACTCGACTGTT
35hom-FRT3-Kan F CTAATAAGTTTGGTCTAATAATTTTTACTTTTT
35hom-Kan R TTGTTCTGTTAATGCCTTGTTTCTGTTATCACG
5hom-F3-Kan F AGCGCTCGGTGCGCTGTTGCTGCGCCTGTTG
5hom-Kan R GTTAGGAGCGCAAGCTGCAGAACACTGGGGA
3hom-Spec F CATTCAGTGTCGGCAGTGGGTCTCTTTGAGAG
3hom-F3-Spec R TGCACCCCGCTGCAAGCTGCAACGCGAGGGA
1hom-F3-Kan F ATGATGATCCAATAAAATTTTTTTATTTCACTC
1hom-Kan R TTTTTCATTAGTACGCTAAAAAATTCAAACAA
6hom-Spec F GCCTAATTTTCCAGTAGGCTGGTTGAGCTTAA
6hom-F3-Spec R AATATGTAGCACTCTGTCGAGTCTTGTTGCAA
EcoRI-KzZPtf1a F AAAAAGAATTCGCAGCCGCCATGGATACGGT
XhoI-zPtf1a R AAAAAACTCGAGTTAGGAAATGAAATTAAAG
PacI-FRT-Kan F CCCCCCTTAATTAAGAAGTTCCTATTCTCTAGA
PacI-FRT-Kan R CCCCCCTTAATTAAGAAGTTCCTATACTTTCTA
300prom F AATATAGGCAGTCGCTTTGTCATCA
3′UTR R AAAAAATTTTATTGGATCATCATATCAGTrequired in both mouse (Fujitani et al., 2006) and zebraﬁsh (Jusuf
et al., 2011) for the generation of inhibitory interneurons that
modulate the signals generated by the photoreceptor cells.
Despite the critical requirement for Ptf1a in the development of
pancreas and cerebellum, the regulatory elements that initiate
expression in these organs have remained elusive. A region of
30 kb encompassing mouse Ptf1a was examined for cis-
regulatory activity (Masui et al., 2008). This study identiﬁed
sequences downstream of the gene that direct transcription to
the hindbrain, spinal cord and retina, but are not active in
cerebellum. The distal portion of the upstream sequence (15.6
to 13.4 kb) harbors two conserved predicted PTF1 binding sites
and directs transcription to the embryonic pancreas. The tran-
scriptional activity in the pancreas is absent in Ptf1a mutants, and
PTF1 complex binds directly to the sequence in vitro, consistent
with autoregulatory function. The upstream enhancer is also active
in the dorsal spinal cord, retina, hindbrain, and cerebellum
(Meredith et al., 2009), where its activity is similarly autoregula-
tory. In the pancreas, the autoregulatory control has been hypothe-
sized to effect an irreversible commitment to the acinar cell
program, although its role has not been directly tested.
We have carried out a comprehensive survey of the genomic
interval spanning zebraﬁsh ptf1a for cis-regulatory activity, focus-
ing speciﬁcally on elements regulating transcription in the devel-
oping pancreas. We identiﬁed an autoregulatory enhancer
analogous to that in the mouse, and showed that the predicted
PTF1 binding sites are both necessary and sufﬁcient for its activity.
We also identiﬁed a sequence capable of initiating early expression
in the pancreas, in a region with high homology between teleosts
and mammals. We describe additional sequences active in regions
of the nervous system that normally express ptf1a, including the
cerebellum. Finally, we tested speciﬁcally for the requirement for
ptf1a autoregulation in pancreas development, and ﬁnd that it is
necessary for early expansion of the exocrine pancreas.GTGATAACAGAAACAAGGCATTAACAG
TCACAGCGATGAACAAATCAAGCACTC
CGGACTTTTAAGGGGAAAAACGTA
GCAATTGGTGTCACGTCCTTTAAT
CAACCACTCACCAGACCCCTTTT
GCTGTGTTGGTGTTGCCCAGTAAC
GGTGTCCATGTGTTGCTATTCCCATCGCCGGCGCAAGTGGTGTGATTCCCACGCCGGC
CGATGGGAATAGCAACACATGGACACCGGTGCTGGGAATCCAGCCACATGCGACCGGT
GTTTGAAGTTCCTATTCTTCAAATAGTATAGGAACTTCCTCTTGGGTTATCAAGAGGG
AGATCCTAATTTTTGTTGACACTCTA
CCGAAGTTCCTATTCTTCAAATAGTATAGGAACTTCTATGGACAGCAAGCGAACCG
TGTCAGAAGAACTCGTCAAGAAG
CTCCGAAGTTCCTATTCTTCAAATAGTATAGGAACTTCTATGGACAGCAAGCGAACCG
TCCTTCAGAAGAACTCGTCAAGAAG
CAGCCAGCCAGGACAGAAATGCCT
CAATGAAGTTCCTATACTATTTGAAGAATAGGAACTTCTTATTTGCCGACTACCTTGGTGA
ACGAAGTTCCTATTCTTCAAATAGTATAGGAACTTCTATGGACAGCAAGCGAACCG
ACGTCAGAAGAACTCGTCAAGAAG
GCACCAGCCAGGACAGAAATGCCT
GTTGAAGTTCCTATACTATTTGAAGAATAGGAACTTCTTATTTGCCGACTACCTTGGTGA
CCTAGATCCATTCACAGGCTTAGACTCTT
GG
AAGTATAGGAACTTCTATGGACAGCAAGCGAACCG
GAGAATAGGAACTTCTCAGAAGAACTCGTCAAGAAG
Fig. 1. Identiﬁcation of teleost ptf1a autoregulatory enhancers. (A) The diagram represents the predicted PTF1 binding sites upstream of the ptf1a coding sequence from the
indicated teleost species; the red squares indicate E boxes (CANNTG) and the blue squares TC-boxes (TTCCC). (B) The transgenes generated for analysis of the autoregulatory
enhancer are diagramed, including the exact sequences of the E and TC boxes of the two proximal sites, and the mutations introduced into them. Transgenes containing all
three (C) or only the two proximal (D) PTF1 binding sites, in conjunction with the heterologous cFosminimal promoter, have similar activity to the entire ptf1a locus at 2 dpf
(C), where they are active in the nervous system and pancreas (arrowhead), and at 5 dpf (D), where they show robust activity in the exocrine pancreas. The indicated
mutations of the E-box and TC-box sequences abolish this activity (Supplementary Fig. 1). (E, F) A 90 bp synthetic enhancer containing the 3 predicted binding sites
recapitulates this expression pattern at 2 dpf (E) and 5 dpf (F), but in addition is active in the retina, a site of endogenous ptf1a expression. medaka: O. latipes, stickleback: G.
aculeatus, fugu: T. rubribes, tetraodon: T. nigroviridis, zebraﬁsh: D. rerio. Scale bars: 200 μm.
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Maintenance of zebraﬁsh stocks
All ﬁsh were maintained under standard conditions, in accor-
dance with regulations of the Institutional Animal Care and Use
Committee of the University of Pennsylvania. Transgenic lines
ptf1a:egfpjh (Godinho et al., 2005) and ins:mCherryjh2 (Pisharath
et al., 2007) have been previously described.Transgenic analysis of non-coding sequences
The +6ptf1a, +11ptf1a and +24ptf1a fragments were produced
by NcoI digest of the BAC CH73-141D4 and cloned into a
Tol2 vector with a minimal mouse cFos promoter and an egfp
reporter followed by the SV40 polyadenylation signal. The remain-
ing non-coding sequences were ampliﬁed with the primers listed
in Table 1.Amplicons produced with primers containing att sites were
cloned in the pDONR221 vector (Invitrogen) through Gateway BP
recombination (Invitrogen). Amplicons without att sites were
cloned in the Gateway entry vector pCR8-TOPO (Invitrogen). The
synthetic autoregulatory enhancer was generated by annealing the
complementary oligos Synth-S and Synth-AS (Table 1). The
annealed double stranded product was then cloned in the pCR8-
TOPO vector. All non-coding sequences were cloned into the pGW-
cfosEGFP (Fisher et al., 2006a, 2006b) vector through Gateway LR
recombination (Invitrogen).
BAC recombineering
BAC recombineering was performed basically as described
(Sharan et al., 2009); primer sequences are listed in Table 1. To
delete the region containing dlgap1a, FRT3 sites ﬂanking the gene
were introduced by recombination. To insert the site upstream
of dlgap1a, the primers 35hom-FRT3-tetR and 35hom-tetF were
used to generate a targeting cassette. Then the CH211-142H2 BAC,
Fig. 2. Survey of ptf1a locus for regulatory activity. (A) The diagram indicates the non-coding sequences, ranging in size from 3 to13 kb and collectively spanning the region
between 17 kb and +48 kb of the transcriptional start site of ptf1a, which were assayed for enhancer activity. The isolated sequences showed transcriptional activity at
1 dpf (B–F) and 3 dpf (G–K) in regions of the nervous system and retina overlapping endogenous ptf1a expression. The 17ptf1a element located upstream of the
autoregulatory enhancer drives non-speciﬁc neuronal expression at 1 dpf (B) and 3 dpf (G). The +6ptf1a enhancer is active in the retina, cerebellum (black arrowhead),
hindbrain and spinal cord at 1 dpf (C) and 3 dpf (H). The +11ptf1a enhancer is also active in the hindbrain, including the cerebellum (black arrowhead), the spinal cord and
more weakly in the retina (D: 1 dpf, I: 3 dpf). The +24ptf1a element activates expression in certain rhombomeres of the hindbrain and in the spinal cord (black arrow)
(E: 1 dpf, J: 3 dpf). The +36ptf1a element is active in the retina, hypothalamus (white arrowhead), ﬁn buds and notochord (F: 1 dpf, K: 3 dpf). Scale bars: 200 μm.
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mCherry, was grown in the EL250 bacterial strain to OD600¼0.6
at 32 1C, followed by manual mixing in a 42 1C waterbath for
15 min to induce recombination proteins. Electrocompetent cells
were prepared and transformed with the ﬁrst targeting cassette
following standard protocols with an Eppendorf Electroporator
2510. After a 1 h recovery, recombinant clones were selected with
the tetracycline. The targeting cassette to introduce a second FRT3
site close to the 3′ end of dlgap1a was generated using the primers
35hom-FRT3-KanF and 35hom-KanR, and transformed as above;
recombinants were selected with kanamycin. After the sequential
recombination steps that introduced FRT3 sites ﬂanking the
dlgap1a region, recombination of the two sites and excision of
the 93 kb sequence was achieved by FLPe induction with arabinose
treatment (0.1% for 1 h at mid-log phase). Recombinant clones at
each step were veriﬁed through PCR or sequencing.
Additional BAC modiﬁcations were made similarly, through
sequential transformations and selections, followed by FLPe-
mediated recombination. To generate a ptf1a coding sequence
resistant to translation blocking MO, ptf1a cDNA was ﬁrst ampli-
ﬁed from the IMAGE clone using primers EcoRI-KzZPtf1a-F and
XhoI-zPtf1a-R, and then ﬂanked by 300 bp homology arms. An
FRT-ﬂanked selection cassette was ampliﬁed using primers
PacIFRTKanF and PacIFRTKanR and added downstream of the ptf1a
cDNA. The entire coding sequence targeting cassette was then
ampliﬁed using the primers 300promF and 3′UTR-R, before
transformation and antibiotic selection. To make the Δ-5-3 BAC,
the primer pairs 5hom-F3-KanF/5hom-KanR and 3hom-SpecF/
3hom-F3-SpecR were used to generate targeting cassettes to ﬂank
the autoregulatory enhancer with FRT sites. Similarly, to make the
Δ+1+6 BAC, the primer pairs 1homF3-KanF/1hom-KanR and
6hom-SpecF/6hom-F3-SpecR were used to amplify the fragments
used to ﬂank the early enhancer with FRT sites. For efﬁcient
transgenesis, a cassette containing the inverted Tol2 arms wastargeted to the chloramphenicol resistance gene of the BAC back-
bone, as previously described (Suster et al., 2011)
Zebraﬁsh embryo injections
Transgenesis with Tol2-based plasmid constructs was performed
as previously described (Fisher et al., 2006a, 2006b). Unless other-
wise noted, consistent reporter gene expression was observed in at
least three independent lines for each construct. For BAC transgen-
esis each embryo was injected with 100 pg BAC DNA and 40 pg Tol2
transposase RNA. To block ptf1a translation, embryos were injected
with 0.5pmoles of ptf1a-MO:CCAACACAGTGTCCATTTTTTGTGC (Gene
Tools) as previously described (Lin et al., 2004).
Photomicroscopy
Embryos were visualized by epiﬂuorescence on a Zeiss V12
Stereomicroscope, and imaged with AxioVision 4.5 software. For
confocal imaging, embryos were anesthetized in Tricaine and
mounted in MatTek glass bottom culture dishes in 1% low melt
SeaPlaque agarose. Images were acquired on an Olympus IX 81
microscope equipped with a Yokogawa CSU 10 scan head with a
Hamamatsu EMCCD camera (model C9100-13, Bridgewater, NJ).
Diode lasers for excitation (488 nm for eGFP and 561 nm for
mCherry) were housed in a Spectral Applied Research launch
(Richmond Hill, Ontario). Hardware was controlled by Slidebook
version 5.0 (Intelligent Imaging Innovations), and confocal image
stacks were processed with ImageJ (〈http://rsbweb.nih.gov/ij〉).
Results
Given the hypothesized importance of Ptf1a autoregulation in
mouse pancreas (Masui et al., 2008) we sought to determine if
Fig. 3. The early pancreatic ptf1a enhancer. (A) The diagram compares the previously published 111 kb to +50 kb ptf1a:egfp BAC transgene, to the truncated -17 kb to
+50 kb ptf1aΔdlgap1:mcherry BAC, with only 17 kb of upstream sequence. (B) Expression of egfp from the longer BAC at 34 hpf completely overlaps mCherry expression from
the shorter BAC (C), including early expression in the pancreas (arrows in B, C); this early pancreatic expression is not seen with the autoregulatory enhancer (D). (E) The
+1ptf1a enhancer is active at 38 hpf in a cluster of cells surrounding the principal islet, marked by expression of the ins:mCherry transgene (F). (H–J) Confocal microscopy of
embryos doubly transgenics for +1ptf1a:EGFP (H) and ins:mCherry (I) at 48 hpf show that the two cell populations are adjacent but do not overlap, as seen in a single 5 mM
slice (J). (G) A 500 bp core of the +1ptf1a enhancer is highly conserved from mammals to teleosts, and contains predicted binding sites for a number of biologically relevant
transcription factors, including Pdx1, Sox9, and Hnf1. DR: zebraﬁsh, HS: human, MM: mouse. Scale bars: 200 μm.
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multiple sequence alignments generated by the PHAST package
did not identify sequences homologous to the characterized
mouse autoregulatory enhancer in any of the teleost species with
available genome sequences (zebraﬁsh, medaka, stickleback, fugu
and tetraodon). We hypothesized that Ptf1a autoregulation is
conserved in teleosts, but that sequence homology is conﬁned to
the enhancer′s transcription factor binding sites. Therefore, we
searched for the motifs CANNTGN6TTCCC (one helical turn spacer)
and CANNTGN16TTCCC (two helical turns spacer), which are based
on the PTF1 binding sites in the Rbpjl promoter (Masui et al., 2007)
and the Ptf1a autoregulatory enhancer (Masui et al., 2008). We
identiﬁed 3 matches to these motifs in the region between 5 kb
and 3 kb upstream of the zebraﬁsh ptf1a transcriptional start site
(Fig. 1). There were no other matches to the PTF1 consensus
binding sequence in the 50 kb on either side of the zebraﬁsh ptf1a
gene, suggesting that this is the only element mediating auto-
regulation of ptf1a expression in zebraﬁsh. Further, we identiﬁed
2–4 matches to the consensus PTF1 binding sequence within
5 kb upstream of the other teleost ptf1a genes (Fig. 1A), strongly
supporting a function for these sites in ptf1a autoregulation.
We tested the ability of sequences containing the predicted
zebraﬁsh PTF1 binding sites to regulate expression of a ﬂuorescent
reporter gene, in conjunction with a heterologous minimal pro-
moter, in transgenic ﬁsh (Fig. 1C and D). A sequence containing all
three predicted sites had activity in the pancreas and the hind-
brain, consistent with function as an autoregulatory enhancer. We
further determined that a shorter fragment containing the two
most proximal predicted PTF1 binding sites was able to similarly
recapitulate endogenous ptf1a expression. Site-directed mutagen-
esis of these two sites abolished enhancer activity (Supplementary
Fig. 1). We also generated a 90 bp synthetic enhancer containing
the three PTF1 sites. The synthetic construct regulated an expres-
sion pattern similar to the intact enhancer, indicating that the
three PTF1 binding sites are sufﬁcient for in vivo activity of the
enhancer (Fig. 1E and F). The synthetic enhancer exhibited activity
in the retina, which although it is an endogenous site of expres-
sion, is not observed with the full autoregulatory enhancer. This
observation suggests that additional sequences in the autoregula-
tory enhancer function to suppress its activity in the retina.
We next sought to identify all additional cis-regulatory ele-
ments associated with ptf1a, in particular those that initiate
expression in the pancreas and cerebellum prior to activation of
the autoregulatory enhancer. We examined the non-coding
sequence between the upstream dlgap1a gene (17 kb upstream)
up to 48 kb downstream of ptf1a for regulatory activity. We
divided the sequence of this interval into 7 consecutive fragments
(Fig. 2A). These were tested as described above for their ability to
direct reporter gene expression to sites of endogenous ptf1a
expression in transgenic zebraﬁsh. We identiﬁed several enhan-
cers that regulated expression of the transgene in the nervous
system, including the hindbrain, retina and spinal cord (Fig. 2).
Three enhancers, +6ptf1a, +11ptf1a and +24ptf1a, organized con-
secutively downstream of ptf1a, regulated expression in different
regions of the hindbrain (Fig. 2 C–E and H–J). Two of these
elements, +6ptf1a and +11ptf1a, also exhibited robust activity in
the anterior hindbrain, including the area corresponding to the
cerebellar primordium (Fig. 2H and I). Three regulatory elements
were active in the spinal cord, speciﬁcally +6ptf1a, +11ptf1a and
+24ptf1a (Fig. 2E and data not shown). Finally, three regulatory
elements (+6ptf1a, +11ptf1a, and +36ptf1a) were active in the
retina (Fig. 2C, D, and F). We further compared the expression
patterns regulated by several neuronal enhancers to that of the
intact locus in double transgenic animals (Supplementary Fig. 2).
We ﬁnd that the hindbrain expression of +11ptf1a:EGFP and the
spinal cord expression of +24ptf1a:EGFP extend to more dorsaldomains than the expression from the intact locus. These results
suggest that genomic context and interactions with surrounding
regulatory elements are necessary to faithfully produce the correct
expression pattern.
The farthest upstream sequence tested, 17ptf1a, directed
expression ubiquitously in neural tissue (Fig. 2B and G), an activity
that might be related to the upstream dlgap1a gene, which
encodes for a synaptic protein (Kim et al., 1997). Additionally,
the most downstream sequence tested, +36ptf1a, was active in the
notochord (Fig. 2F), expression likely related to the downstream
gene si:ch211-207d6.2, whose murine homolog Sickle tail is
expressed in the notochord and required for proper vertebrae
development (Semba et al., 2006).
To test whether the interval described above contains all
necessary regulatory sequences, we utilized a bacterial artiﬁcial
chromosome (BAC) transgene that faithfully recapitulates endo-
genous ptf1a expression (Park et al., 2008). The neighboring gene
upstream of ptf1a differs between teleosts and mammals. We
expect that regulatory elements conserved among vertebrates will
remain syntenic to the gene throughout evolution and therefore
we predicted that conserved regulatory elements would lie within
the region bounded by the nearest upstream gene, dlgap1a. We
deleted 93 kb of upstream sequence, including the dlgap1a gene
(Fig. 3A). We showed that the truncated BAC (with 17 kb of direct
upstream sequence and 50kb of downstream sequence) has
activity identical to the original BAC (Fig. 3B–D) and therefore
contains all necessary regulatory elements for proper ptf1a
expression.
Within the tested interval, we identiﬁed a single region,
+1ptf1a, which regulated expression in the early pancreas. The
cells in which +1ptf1a is active are in close proximity to but do not
overlap with the dorsal bud derived β-cells, marked by the
expression of the insulin:mCherry transgene (Fig. 3E–J). This
localization is consistent with the position of the ventral bud
derived pancreatic progenitors that surround the earlier appearing
cluster of endocrine cells of the principal islet. Upon expansion of
the pancreas and cytodifferentiation of exocrine cells, +1ptf1a:egfp
activity persisted in a limited region surrounding the principal
islet at least until 5 dpf (Supplementary Fig. 3). The persistent
ﬂuorescence may represent GFP perdurance in slowly dividing
cells, or perhaps correspond to ongoing newly generated exocrine
precursors in which the early enhancer continues to be active. The
+1ptf1a element spans 5 kb immediately downstream of the ptf1a
gene and has a high degree of sequence conservation to other
species, including human and mouse, suggesting a conserved
functional role. Speciﬁcally, this interval contained a 527 bp
sequence that is 79% identical between zebraﬁsh and human,
and 96% identical between mouse and human (Fig. 3K). We tested
the highly conserved shorter sequence for its ability to direct
expression to the pancreas, but found that, in isolation, it lacks
enhancer activity.
To further characterize the spatial and temporal activities of the
two pancreatic enhancers, we compared expression regulated by
them to that of the intact ptf1a locus. Embryos transgenic for the
early enhancer, the autoregulatory enhancer or the entire BAC
were assayed by in situ hybridization for pancreatic egfp expres-
sion at 4 h intervals between 30 hpf and 46 hpf (Fig. 4). Consistent
with previous reports, expression from the intact BAC was ﬁrst
seen at 34 hpf (24/24 embryos, Fig. 4A). While expression in the
+1ptf1a:egfp transgenics was variable, a fraction of embryos had
pancreatic expression at 34hpf (Fig. 4B) and expression was
observed in the majority of embryos (28/36) by 38 hpf (Fig. 4D).
At all time points, the expression regulated by the +1ptf1a
enhancer was in a subset of cells in the domain in which the
intact locus showed expression. In contrast, the autoregulatory
enhancer did not regulate detectable pancreatic expression until
Fig. 4. Activity of pancreatic ptf1a enhancers relative to the intact locus. Activity of the early +1ptf1a (B, D, G) and the autoregulatory (E, H) enhancers was assayed in
transgenic embryos by in situ hybridization for egfp. For comparison, egfp expression is also shown for the intact locus in ptf1a:egfpjh1 transgenic embryos (A, C, F). At 30 hpf,
none of the embryos had detectable expression in pancreatic precursors (data not shown). At 34 hpf (A, B) and 38 hpf (C–E), all ptf1a:EGFPjh1 embryos (n¼24 and 40) showed
a group of positive cells stretched across the midline from left anterior to right posterior (A, C), a subset of embryos transgenic for the early enhancer showed smaller groups
of positive cells, in the left anterior endoderm (B, D), while all embryos transgenic for the autoregulatory enhancer lacked expression, shown at 38 hpf (E). At 42 hpf, ptf1a:
egfpjh1 embryos had larger, less scattered groups of positive cells (F), while both the early enhancer (G) and the autoregulatory enhancer (H) were active in a subset of cells in
the same domain. For all photographs, yolk was dissected away and the endoderm is shown from the ventral side; embryos are oriented with anterior to the left and left to
the top.
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expressing the intact locus.
We identiﬁed two regulatory elements apparently controlling
ptf1a expression in the pancreas: an early enhancer that initiates
expression, and an autoregulatory enhancer that maintains or
augments expression. Because the early enhancer has restricted
spatial and temporal activity, and because we failed to identify
additional enhancers that control ptf1a expression in the mature
pancreas, we hypothesized that autoregulation has a major role in
development of the pancreas following its initial speciﬁcation. To
test this hypothesis, we examined the effect of the lack of
autoregulatory ptf1a control on pancreatic development. We
altered a BAC containing ptf1a through the introduction of synon-
ymous substitutions in the coding sequence, rendering the tran-
script resistant to a translation-blocking morpholino (MO) that
efﬁciently depletes endogenous PTF1a and inhibits development
of the ventral pancreatic bud (Lin et al., 2004). We further deleted
the entire autoregulatory element from the BAC, generating the
Δ-5-3 BAC transgene that expresses ptf1a under control of the full
complement of characterized regulatory elements minus the
autoregulatory enhancer. We subsequently established stable
transgenic lines with the two BAC transgenes.
We tested the ability of the Δ-5-3 BAC to rescue pancreatic
development, by MO injection into embryos transgenic for theptf1a:egfp BAC (Fig. 5). In control embryos, MO injection almost
completely abolished visible exocrine pancreas tissue at 3 or 5 dpf
(4 partial pancreas/137 embryos; Fig. 5C). Presence of the BAC
encoding MO-resistant ptf1a rescued pancreas development,
wholly or partially, in a substantial fraction of morphants (22/88
embryos, or 50% of expected 44 BAC carriers; Fig. 5D, F). In
contrast, the Δ-5-3 BAC failed to rescue pancreas development
(1 partial pancreas/90 embryos, or 45 expected BAC carriers; Fig.
5E). The Δ-5-3 BAC rescues represent the combined results of
rescues performed in 2 independent transgenic lines. These ﬁndings
indicate that ptf1a autoregulation has a very critical role during early
pancreatic development, and lack of the relevant transcriptional
activity leads to an early failure of the pancreas to expand.
To address the role of the +1ptf1a enhancer in pancreas
speciﬁcation, we similarly engineered a BAC encoding for MO-
resistant ptf1a transcript and lacking the 5 kb region correspond-
ing to the +1ptf1a enhancer, the Δ+1+6 BAC. As above, we
depleted endogenous ptf1a through MO injections in ptf1a:egfp
transgenics. We then compared the abilities of the Δ+1+6 BAC and
the intact BAC to rescue pancreas formation in 5 dpf mosaic
transgenic larvae. In MO-injected embryos, none (0/63) had visible
exocrine pancreas tissue at 5 dpf, In embryos injected with
MO and the intact BAC, a fraction of larvae had pancreas tissue
(16/196) at 5 dpf, consistent with the ability of the same BAC to
Fig. 5. ptf1a autoregulation is required for exocrine pancreas development. (A) The diagram indicates the endogenous ptf1a locus (top line). In the control BAC (middle line)
the ptf1a coding sequence was modiﬁed by synonymous substitutions and the addition of a Kozak sequence (at bottom) resulting in a transcript resistant to the translation
blocking MO. The Δ-5-3 BAC has an additional 2 kb deletion removing the autoregulatory enhancer. (B) At 5 dpf, the ptf1a:egfp BAC shows robust expression in exocrine
pancreas, as well as some hindbrain expression. In ﬁsh without a rescuing BAC, MO injection abolished exocrine pancreas development at 5 dpf (C), while the presence of the
control BAC expressing MO-resistant ptf1a allowed complete (D) or partial (F) pancreas development at the same stage. In contrast, the Δ-5-3 BAC failed to rescue ventral
pancreas development (E), although hindbrain expression was apparently normal. Scale bars: 200 μm.
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ingly, pancreas tissue was observed in a larger fraction (43/209) of
embryos injected with MO and the Δ+1+6 BAC. While different
degrees of mosaicism between embryos leads to variability in
these transient assays, comparison of the best pancreas rescues
seen for each BAC demonstrates that the control BAC was able to
fully rescue pancreas formation (Fig. 6C, E, and G) while the BAC
lacking the early enhancer was only able to promote the formation
of a hypoplastic pancreas (Fig. 6D, F, and H); the mean pancreas
size in the embryos receiving the BAC lacking the early enhancer
was only 35% the average size of the pancreas rescued by the
intact BAC (Fig. 6B).Discussion
Ptf1a has demonstrated importance in neuronal speciﬁcation
and development of the exocrine pancreas. However, prior to our
work, identiﬁed cis-regulatory elements could only account for
part of the transcriptional regulation of the gene. Therefore, we
undertook a comprehensive, unbiased analysis of the zebraﬁsh
ptf1a locus to fully characterize its regulatory context. Previous
work had established the presence of an autoregulatory enhancer
upstream of mouse Ptf1a (Masui et al., 2008; Meredith et al.,
2009). Based on identiﬁcation of consensus binding site sequences
for PTF1, we identiﬁed a similarly functioning enhancer upstream
of the zebraﬁsh gene. The region we identiﬁed as the autoregula-
tory enhancer contains three potential PTF1 binding sites, which
we showed are both necessary and sufﬁcient for its function.
We also computationally identiﬁed similar regions upstream of
multiple teleost ptf1a genes, suggesting that autoregulation of
ptf1a is a deeply conserved feature. It is important to note that
sequence conservation tools did not identify the autoregulatory
sequences in teleosts, and therefore the absence of recognizablesequence conservation does not preclude the presence of func-
tional conservation.
Ptf1a has an important role in promoting inhibitory fates in
several neuronal populations. Previous work in mice identiﬁed a
downstream regulatory element with activity in the hindbrain,
spinal cord and retina (Masui et al., 2008; Meredith et al., 2009),
although it did not direct expression to the cerebellum and
additionally showed ectopic activity in populations of excitatory
neurons of the spinal cord. Here we report the identiﬁcation of
several independent enhancers in zebraﬁsh that recapitulate
different subsets of the endogenous expression pattern in the
hindbrain, spinal cord, and the cerebellum. Surprisingly, although
the +6ptf1a sequence is highly similar to the orthologous sequence
in the mouse, a larger transgene encompassing the orthologous
sequence showed no cerebellar activity in transgenic mice. This
discrepancy could be due to divergence of the regulatory
sequences in the two species or the presence of additional
regulatory elements in the zebraﬁsh sequence. We additionally
identiﬁed multiple enhancers with activity in different regions of
the hindbrain, suggesting the presence of diverse regulatory
mechanisms activating ptf1a expression in different regions of
the hindbrain. Whether these enhancers with partially overlap-
ping expression patterns synergize in vivo to create exact borders
of expression as suggested elsewhere (Perry et al., 2011) or
whether these enhancers operate in a modular fashion will be
interesting to determine in the future.
The region immediately downstream of zebraﬁsh ptf1a was
able to drive expression in the pancreatic progenitors, an activity
not found for the orthologous mouse sequence (Masui et al.,
2008). While this discrepancy could be due to divergence between
the mouse and zebraﬁsh sequences, other reasons could account
for the differences. First, the mouse downstream regulatory
sequence excluded 330 bp corresponding to the 3′UTR and a
further 536bp of poorly conserved sequence directly downstream
Fig. 6. Loss of activity of the early +1ptf1a enhancer results in the formation of a hypoplastic pancreas. (A) The diagram indicates the endogenous ptf1a locus (top line). In the
control BAC (middle line) the ptf1a coding sequence was modiﬁed by synonymous substitutions and the addition of a Kozak sequence (as in Fig. 5) resulting in a transcript
resistant to the translation blocking MO. The Δ+1+6 BAC has a 5 kb deletion removing the early enhancer. (B) Pancreas size was measured at 5 dpf following an injection of
ptf1a MO and either the control BAC or the Δ+1+6 BAC. (B) Rescues with the Δ+1+6 BAC resulted in a signiﬁcantly smaller pancreas size (p¼0.0158). Three examples are
shown of the maximum pancreata sizes measured at 5 dpf, after rescue with either the control BAC (C, E, G) or the BAC with the deletion of the early enhancer (D, F, H). Scale
bars: 200 μm.
E. Pashos et al. / Developmental Biology 381 (2013) 471–481 479
E. Pashos et al. / Developmental Biology 381 (2013) 471–481480of the mouse 3′UTR. It is possible that the early pancreatic activity
requires sequences in this region. We also found that the activity
of this enhancer was sensitive to position effects, necessitating the
screening of a relatively large number of founders to identify those
with early pancreatic expression. The extremely high degree of
conservation of this downstream region suggests that the mechan-
isms controlling initiation of ptf1a expression in the pancreas are
conserved between teleosts and mammals. There are predicted
binding sites for Hnf1, Sox9, and Pdx1 conserved in this region
from teleosts to mammals, all attractive candidates for regulators
of early ptf1a expression and speciﬁcation of the exocrine pro-
genitor cells. With the identiﬁcation of this enhancer, the in vivo
role for all of these factors in inducing ptf1a and subsequent
pancreatic development can be addressed directly.
We tested the requirement for the identiﬁed early enhancer
region in exocrine pancreas speciﬁcation. Somewhat surprisingly,
we found that a BAC lacking the early enhancer regionwas capable
in mosaic injected larvae of rescuing the formation of exocrine
pancreas tissue, and in fact did so at a higher frequency than the
intact BAC, although the average size of rescued pancreatic tissue
was signiﬁcantly smaller. These data suggest that there are
additional sequences outside of the deleted enhancer region that
can lead to a low level of ptf1a expression; once the expression
meets the threshold to activate the autoregulatory enhancer, it is
self-sustaining. Interestingly, injection of the Δ+1+6 BAC into
ptf1a:egfp transgenics in the absence of MO leads to ectopic GFP
expression in a fraction of embryos, in some cases even apparent
development of pancreatic tissue bilaterally (data not shown). We
hypothesize that the deleted region contains both positive reg-
ulatory elements that increase the level of ptf1a in the early
pancreas, but also negative regulatory sequences that help to
prevent ectopic expression in adjacent non-pancreatic endoderm.
It has been hypothesized that Ptf1a autoregulation plays a role
in late pancreatic development and in the mature pancreas to
stabilize commitment to the exocrine lineage (Masui et al., 2008).
As a direct test of this hypothesis, we removed the autoregulatory
enhancer from a BAC transgene containing the entire regulatory
region of ptf1a. In contrast to the previously described ptf1a
hypomorphic mutant (Dong et al., 2008), Ptf1a encoded by the
BAC lacking the autoregulatory enhancer is fully functional to
activate all of its target genes. However, in the absence of
expression from the endogenous ptf1a locus, as in a null mutant
or morphant, the ptf1a locus on the BAC is incapable of regulating
its own expression. In the absence of this autoregulatory loop, we
ﬁnd that ptf1a cannot support development of the exocrine
pancreas. Our results thus reveal a requirement for ptf1a auto-
regulation much earlier during embryonic development than
expected. These results demonstrate that ptf1a autoregulation
has a critical role in pancreatic development and unlike other
developmental regulatory elements, whose deletion might cause
no effect or only produce effects under environmental stress
(Perry et al., 2011; Frankel et al., 2010), the autoregulatory function
is strictly required for ventral pancreas expansion. The presence of
sequences with predicted autoregulatory function in the teleost
loci described here and in other vertebrates (Masui et al., 2008)
suggests that autoregulation is a well conserved and critical aspect
of ptf1a expression, a hypothesis supported by our functional BAC
rescue assays.
Our work has produced a more complete picture of Ptf1a
regulation, including the ﬁrst evidence of regions regulating initial
expression in the pancreas and cerebellum, the two structures
most severely affected in mutants. It will now be possible to test
speciﬁc hypotheses about transcription factors and signaling path-
ways required for Ptf1a induction. In addition, we have directly
tested the requirement for autoregulation at the locus, and shown
that it is critical for early development of the exocrine pancreas.The transgenic model we have generated will also be useful in
better understanding the role of Ptf1a autoregulation in the
allocation and commitment of pancreatic cells to the exocrine
and endocrine lineage. Previous studies have shown that main-
taining Ptf1a expression during embryonic development blocks
endocrine differentiation (Schaffer et al., 2010) and antagonizing
ptf1a function postembryonically can lead to an exocrine-to-
endocrine conversion (Hesselson et al., 2011). Our BACs lacking
the autoregulatory enhancer can further be used to examine the
requirement for ptf1a autoregulation in processes of pancreatic
development, such as the expansion and maintenance of pancrea-
tic progenitors and the balance of exocrine and endocrine pro-
genitors. These efforts will ultimately help in understanding cell
fate choices in the pancreas and enable manipulations of these
processes toward the generation of desired cell types.Acknowledgments
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